Cite
HARVARD Citation
Khan, K. et al. (2020). Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study. Scottish medical journal. 65 (4), pp. 149-153. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khan, K. et al. (2020). Angiotensin converting enzyme inhibitors do not increase the risk of poor outcomes in COVID-19 disease. A multi-centre observational study. Scottish medical journal. 65 (4), pp. 149-153. [Online].